• [1]
    Berendt, R.F., Knutsen, G.L., Powanda, M.C. (1978) Nonhuman primate model for the study of respiratory Klebsiella pneumoniae infection. Infect. Immun. 22, 275281.
  • [2]
    Carpenter, J.L. (1990) Klebsiella pulmonary infections: occurrence at one medical center and review. Rev. Infect. Dis. 12, 672682.
  • [3]
    Cryz, S.J., Mortimer, P.M. (1986) Seroepidemiologic of Klebsiella bacteremic isolates and implications for vaccine development. J. Clin. Microbiol. 23, 687690.
  • [4]
    de la Torre, M.G., Romero-Vivas, J. (1985) Klebsiella bacteremia: an analysis of 100 episodes. Rev. Infect. Dis. 7, 143150.
  • [5]
    Donta, S.T., Peduzzi, P. (1996) Immunoprophylaxis against Klebsiella and Pseudomonas infections. J. Infect. Dis. 174, 537543.
  • [6]
    Fung, C.P., Hu, B.S. (2000) A 5-year study of the seroepidemiology of Klebsiella pneumoniae: high prevalence of capsular serotype K1 in Taiwan and implications for vaccine efficacy. J. Infect. Dis. 181, 20752079.
  • [7]
    Glanz, S.A. and Slinker, B.K. (1990) Primer of Applied Regression and Analysis of Variance. MacGraw-Hill, New York.
  • [8]
    Hansen, D.S., Mestre, F. (1999) Klebsiella pneumoniae lipopolysaccharide O typing: revision of prototype strains and O-group distribution among clinical isolates from different sources and countries. J. Clin. Microbiol. 37, 5662.
  • [9]
    Held, T.K., Jendrike, N.J. (2000) Binding to and opsonophagocytic activity of O-antigen specific monoclonal antibodies against encapsulated and nonencapsulated Klebsiella pneumoniae serotype O1 strains. Infect. Immun. 68, 24022409.
  • [10]
    Held, T.K., Trautmann, M. (1992) Monoclonal antibodies against Klebsiella capsular polysaccharide reduces severity and hematogenic spread of experimental Klebsiella pneumoniae pneumonia. Infect. Immun. 60, 17711778.
  • [11]
    Jong, G.M., Hsiue, T.R. (1995) Rapidly fatal outcome of bacteremic Klebsiella pneumoniae pneumonia in alcoholics. Chest 107, 214217.
  • [12]
    Mandine, E., Salles, E.F. (1990) Murine monoclonal antibodies to Klebsiella pneumoniae protect against lethal endotoxinemia and experimental infection with capsulated Klebsiella pneumoniae. Infect. Immun. 58, 28282833.
  • [13]
    Meno, Y., Amano, K. (1990) Morphological evidence for penetration of anti-O antibodies through the capsule of Klebsiella pneumoniae. Infect. Immun. 58, 14211428.
  • [14]
    Pollack, M. (1976) Significance of circulating capsular antigen in Klebsiella infections. Infect. Immun. 13, 15431548.
  • [15]
    Rukavina, T., Ticac, B. (1997) Protective effect of antilipopolysaccharide monoclonal antibodies in experimental Klebsiella infection. Infect. Immun. 65, 17541760.
  • [16]
    Tomas, J.M., Camprubi, S. (1991) Surface exposure of O1 serotype lipopolysaccharide in Klebsiella pneumoniae strains expressing different K antigens. Infect. Immun. 59, 20062011.
  • [17]
    Trautmann, M., Cross, A.S. (1996) Evaluation of a competitive ELISA method for the determination of Klebsiella O antigens. J. Med. Microbiol. 44, 4451.
  • [18]
    Trautmann, M., Cryz, S.J. (1988) A murine monoclonal antibody against Klebsiella capsular polysaccharide is opsonic in vitro and protects against experimental Klebsiella pneumoniae infection. Microb. Pathogen. 5, 177187.
  • [19]
    Trautmann, M., Ghandchi, A. (1991) An enzyme-linked immunosorbent assay for the detection of soluble Klebsiella pneumoniae capsular polysaccharide. J. Microb. Methods 13, 305313.
  • [20]
    Trautmann, M., Held, T.K. (1998) Bacterial lipopolysaccharide-specific antibodies in commercial human immunoglobulin preparations: superior antibody content of an IgM-enriched product. Clin. Exp. Immunol. 111, 8190.
  • [21]
    Trautmann, M., Ruhnke, M. (1997) O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections. Clin. Diagn. Lab. Immunol. 4, 550555.
  • [22]
    Trautmann, M., Vogt, K. (1994) A murine monoclonal antibody defines a unique epitope shared by Klebsiella lipopolysaccharides. Infect. Immun. 62, 12821288.
  • [23]
    Cortes, G., Borrell, N. (2002) Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect. Immun. 70, 25832590.
  • [24]
    Cryz, S.J., Cross, A.S. (1986) Activity of intravenous immune globulins against Klebsiella. J. Lab. Clin. Med. 108, 182189.
  • [25]
    Alberti, S., Alvarez, D. (1996) Analysis of complement C3 deposition and degradation on Klebsiella pneumoniae. Infect. Immun. 64, 47264732.
  • [26]
    Tomas, J.M., Benedi, V.J. (1986) Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity. Infect. Immun. 54, 8589.
  • [27]
    Alvarez, D., Merino, S. (2000) Capsular polysaccharide is a major complement resistance factor in lipopolysaccharide O side chain-deficient Klebsiella pneumoniae clinical isolates. Infect. Immun. 68, 953955.
  • [28]
    Lepper, P.M., Held, T.K. (2002) Clinical implications of antibiotic induced endotoxin release in septic shock. Intensive Care Med. 28, 824833.